Income Statement (TTM)
Polomar Health Services, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2023 12-31 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Change (%) | 32.02 | 6.48 | -15.42 | -18.14 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 |
| Change (%) | 327.22 | 52.20 | -34.16 | -14.15 | |
| % of Revenue | 10.26 | 33.21 | 47.47 | 36.95 | 38.75 |
| Gross Operating Profit | 0 | 0 | 0 | 0 | 0 |
| Change (%) | -1.74 | -16.25 | 1.52 | -20.48 | |
| % of Revenue | 89.74 | 66.79 | 52.53 | 63.05 | 61.25 |
| SG&A | 0 | 1 | 1 | 2 | 2 |
| Change (%) | 55.07 | 79.34 | 19.20 | 23.09 | |
| % of Revenue | 1,143.25 | 1,342.85 | 2,261.66 | 3,187.17 | 4,792.47 |
| R&D | |||||
| Change (%) | |||||
| % of Revenue | |||||
| OpEx | 0 | 1 | 1 | 2 | 2 |
| Change (%) | 57.49 | 78.69 | 18.10 | 22.66 | |
| % of Revenue | 1,153.51 | 1,376.06 | 2,309.13 | 3,224.12 | 4,831.23 |
| Operating Income | -0 | -1 | -1 | -2 | -2 |
| Change (%) | 59.91 | 84.35 | 19.62 | 23.97 | |
| % of Revenue | -1,053.51 | -1,276.06 | -2,209.13 | -3,124.12 | -4,731.23 |
| Interest Expense | -0 | -0 | -0 | -0 | |
| Change (%) | 99.07 | 50.70 | |||
| % of Revenue | -1.18 | -71.12 | -167.38 | -308.16 | |
| Net Income | -1 | -1 | -1 | -2 | -2 |
| Change (%) | 40.61 | 62.24 | 22.10 | 25.33 | |
| % of Revenue | -1,405.21 | -1,496.62 | -2,280.25 | -3,291.50 | -5,039.38 |
Source: Capital IQ
